Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

BACKGROUND: Recent studies strongly suggest that due to the limitations and risks of biopsy, as well as the improvement of the diagnostic accuracy of biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Comp Hepatol
Autors principals: Poynard, Thierry, Imbert-Bismut, Françoise, Munteanu, Mona, Messous, Djamila, Myers, Robert P, Thabut, Dominique, Ratziu, Vlad, Mercadier, Anne, Benhamou, Yves, Hainque, Bernard
Format: Artigo
Idioma:Inglês
Publicat: BMC 2004
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522750/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15387887/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-5926-3-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars